UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical benefits and bioequivalence of vortioxetine oral drop solution versus oral tablets

Journal of psychopharmacology (Oxford), 2024-02, Vol.38 (2), p.156-161

2024

Volltextzugriff (PDF)

Are self-reported and self-monitored adherence good proxies for reaching relevant plasma concentrations?: Experiences from a study of anti-depressants in healthy volunteers

Clinical trials (London, England), 2021-08, Vol.18 (4), p.505-510

2021

Volltextzugriff (PDF)

Does ethnicity impact CYP2D6 genotype–phenotype relationships?

Clinical and translational science, 2023-06, Vol.16 (6), p.1012-1020

2023

Volltextzugriff (PDF)

Cytochrome P450 2D6 genotype–phenotype characterization through population pharmacokinetic modeling of tedatioxetine

CPT: pharmacometrics and systems pharmacology, 2021-09, Vol.10 (9), p.983-993

2021

Volltextzugriff (PDF)

Vortioxetine: Clinical Pharmacokinetics and Drug Interactions

Clinical pharmacokinetics, 2018-06, Vol.57 (6), p.673-686

2018

Volltextzugriff (PDF)

Population pharmacokinetics of eptinezumab in paediatric patients with migraine and dose selection for phase 3 paediatric migraine studies

Basic & clinical pharmacology & toxicology, 2024-10, Vol.135 (4), p.512-522

2024

Volltextzugriff (PDF)

Estimating the In Vivo Function of CYP2D6 Alleles through Population Pharmacokinetic Modeling of Brexpiprazole

Clinical pharmacology and therapeutics, 2023-02, Vol.113 (2), p.360-369

2023

Volltextzugriff (PDF)

Quantification of In Vivo Metabolic Activity of CYP2D6 Genotypes and Alleles Through Population Pharmacokinetic Analysis of Vortioxetine

Clinical pharmacology and therapeutics, 2021-01, Vol.109 (1), p.150-159

2021

Volltextzugriff (PDF)

Intravenous vortioxetine to accelerate onset of effect in major depressive disorder: a 7-day randomized, double-blind, placebo-controlled exploratory study

International clinical psychopharmacology, 2020-11, Vol.35 (6), p.305-312

2020

Volltextzugriff (PDF)

Validation of a Population Pharmacokinetic Model of Vortioxetine Using Therapeutic Drug Monitoring Data

Clinical pharmacokinetics, 2021-11, Vol.60 (11), p.1475-1486

2021

Volltextzugriff (PDF)

Intravenous vortioxetine to accelerate onset of effect in major depressive disorder: a 2-week, randomized, double-blind, placebo-controlled study

International clinical psychopharmacology, 2019-07, Vol.34 (4), p.153-160

2019

Volltextzugriff (PDF)

Stress-free blood sampling in minipigs: A novel method for assessing 24-h cortisol profiles and drug effects on diurnal and ultradian rhythms

Journal of pharmacological and toxicological methods, 2024-05, Vol.127, p.107504-107504, Article 107504

2024

Volltextzugriff (PDF)

Population Pharmacokinetic Meta‐Analysis of Vortioxetine in Healthy Individuals

Basic & clinical pharmacology & toxicology, 2014-12, Vol.115 (6), p.552-559

2014

Volltextzugriff (PDF)

The Clinical Pharmacokinetics of Lu AA21004 and its Major Metabolite in Healthy Young Volunteers

Basic & clinical pharmacology & toxicology, 2012-09, Vol.111 (3), p.198-205

2012

Volltextzugriff (PDF)

Antitumor effect of radioactive cisplatin ( 191Pt) on nude mice

International journal of radiation oncology, biology, physics, 2001-03, Vol.49 (3), p.827-832

2001

Volltextzugriff (PDF)

Pharmacokinetics and Safety of Vortioxetine in the Chinese Population

Advances in therapy, 2019-11, Vol.36 (11), p.3134-3146

2019

Volltextzugriff (PDF)

Population pharmacokinetics of nalmefene in healthy subjects and its relation to μ‐opioid receptor occupancy

British journal of clinical pharmacology, 2016-02, Vol.81 (2), p.290-300

2016

Volltextzugriff (PDF)

Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 1, a pharmacokinetic/pharmacodynamic comparison with paroxetine in healthy men

Journal of psychopharmacology (Oxford), 2015-10, Vol.29 (10), p.1085-1091

2015

Volltextzugriff (PDF)

Occupancy of the Serotonin Transporter after Administration of Lu AA21004 and its Relation to Plasma Concentration in Healthy Subjects

Basic & clinical pharmacology & toxicology, 2012-04, Vol.110 (4), p.401-404

2012

Volltextzugriff (PDF)

Comparative renal, hepatic, and bone marrow toxicity of Cisplatin and radioactive Cisplatin (191Pt) in Wistar rats

Cancer biotherapy & radiopharmaceuticals, 2006-10, Vol.21 (5), p.528-534

2006

Volltextzugriff (PDF)

A Population Pharmacokinetic–Pharmacodynamic Meta‐Analysis of Vortioxetine in Patients with Major Depressive Disorder

Basic & clinical pharmacology & toxicology, 2016-05, Vol.118 (5), p.344-355

2016

Volltextzugriff (PDF)

Accuracy of the quantification of organ activity from planar gamma camera images

Cancer biotherapy & radiopharmaceuticals, 2003-02, Vol.18 (1), p.125-131

2003

Volltextzugriff (PDF)

Pharmacokinetics and Safety of Vortioxetine in Pediatric Patients

Journal of child and adolescent psychopharmacology, 2017-08, Vol.27 (6), p.526-534

2017

Volltextzugriff (PDF)

The Clinical Pharmacokinetics of L u AA 21004 and its Major Metabolite in Healthy Young Volunteers

Basic & clinical pharmacology & toxicology, 2012-09, Vol.111 (3), p.198-205

2012

Volltextzugriff (PDF)

In vitro toxicity of 191Pt-labeled cisplatin to a human cervical carcinoma cell line (ME-180)

International journal of radiation oncology, biology, physics, 2000-03, Vol.46 (5), p.1275-1280

2000

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(42)
Dissertationen
(1)

Sprache

Englisch
(43)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Clinical benefits and bioequivalence of vortioxetine oral drop solution versus oral tablets

Are self-reported and self-monitored adherence good proxies for reaching relevant plasma concentrations?: Experiences from a study of anti-depressants in healthy volunteers

Does ethnicity impact CYP2D6 genotype–phenotype relationships?

Cytochrome P450 2D6 genotype–phenotype characterization through population pharmacokinetic modeling of tedatioxetine

Vortioxetine: Clinical Pharmacokinetics and Drug Interactions

Population pharmacokinetics of eptinezumab in paediatric patients with migraine and dose selection for phase 3 paediatric migraine studies

Estimating the In Vivo Function of CYP2D6 Alleles through Population Pharmacokinetic Modeling of Brexpiprazole

Quantification of In Vivo Metabolic Activity of CYP2D6 Genotypes and Alleles Through Population Pharmacokinetic Analysis of Vortioxetine

Intravenous vortioxetine to accelerate onset of effect in major depressive disorder: a 7-day randomized, double-blind, placebo-controlled exploratory study

Validation of a Population Pharmacokinetic Model of Vortioxetine Using Therapeutic Drug Monitoring Data

Intravenous vortioxetine to accelerate onset of effect in major depressive disorder: a 2-week, randomized, double-blind, placebo-controlled study

Stress-free blood sampling in minipigs: A novel method for assessing 24-h cortisol profiles and drug effects on diurnal and ultradian rhythms

Population Pharmacokinetic Meta‐Analysis of Vortioxetine in Healthy Individuals

The Clinical Pharmacokinetics of Lu AA21004 and its Major Metabolite in Healthy Young Volunteers

Antitumor effect of radioactive cisplatin ( 191Pt) on nude mice

Pharmacokinetics and Safety of Vortioxetine in the Chinese Population

Population pharmacokinetics of nalmefene in healthy subjects and its relation to μ‐opioid receptor occupancy

Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 1, a pharmacokinetic/pharmacodynamic comparison with paroxetine in healthy men

Occupancy of the Serotonin Transporter after Administration of Lu AA21004 and its Relation to Plasma Concentration in Healthy Subjects

Comparative renal, hepatic, and bone marrow toxicity of Cisplatin and radioactive Cisplatin (191Pt) in Wistar rats

A Population Pharmacokinetic–Pharmacodynamic Meta‐Analysis of Vortioxetine in Patients with Major Depressive Disorder

Accuracy of the quantification of organ activity from planar gamma camera images

Pharmacokinetics and Safety of Vortioxetine in Pediatric Patients

The Clinical Pharmacokinetics of L u AA 21004 and its Major Metabolite in Healthy Young Volunteers

In vitro toxicity of 191Pt-labeled cisplatin to a human cervical carcinoma cell line (ME-180)

Suchergebnisse filtern